Okuda, K.; Umemura, A.; Umemura, S.; Kataoka, S.; Taketani, H.; Seko, Y.; Nishikawa, T.; Yamaguchi, K.; Moriguchi, M.; Kanbara, Y.;
et al. Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers 2021, 13, 1515.
https://doi.org/10.3390/cancers13071515
AMA Style
Okuda K, Umemura A, Umemura S, Kataoka S, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y,
et al. Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers. 2021; 13(7):1515.
https://doi.org/10.3390/cancers13071515
Chicago/Turabian Style
Okuda, Keiichiro, Atsushi Umemura, Shiori Umemura, Seita Kataoka, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshihiro Kanbara,
and et al. 2021. "Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis" Cancers 13, no. 7: 1515.
https://doi.org/10.3390/cancers13071515
APA Style
Okuda, K., Umemura, A., Umemura, S., Kataoka, S., Taketani, H., Seko, Y., Nishikawa, T., Yamaguchi, K., Moriguchi, M., Kanbara, Y., Arbiser, J. L., Shima, T., Okanoue, T., Karin, M., & Itoh, Y.
(2021). Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers, 13(7), 1515.
https://doi.org/10.3390/cancers13071515